![In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac](https://c5.rgstatic.net/m/435982309481010/images/template/default/author/author_default_m.jpg)
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac
![EP3024822B1 - Substituted oxopyridine derivatives and their use as factor xia and plasma kallikrein inhibitors - Google Patents EP3024822B1 - Substituted oxopyridine derivatives and their use as factor xia and plasma kallikrein inhibitors - Google Patents](https://patentimages.storage.googleapis.com/a5/e7/bb/e1a534d7b69d08/imgb0030.png)
EP3024822B1 - Substituted oxopyridine derivatives and their use as factor xia and plasma kallikrein inhibitors - Google Patents
![PDF) Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy PDF) Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy](https://www.researchgate.net/publication/262784411/figure/fig2/AS:202564432863239@1425306532368/Mean-scores-of-pain-and-inflammation-at-Day-30_Q320.jpg)
PDF) Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy
![WO2016046157A1 - Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives - Google Patents WO2016046157A1 - Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives - Google Patents](https://patentimages.storage.googleapis.com/5a/90/61/d670e7fc9ddc8b/imgf000096_0001.png)
WO2016046157A1 - Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives - Google Patents
![PDF) Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy PDF) Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy](https://www.researchgate.net/publication/262784411/figure/tbl2/AS:202564432863236@1425306532284/Surgical-characteristics-of-study-groups_Q320.jpg)
PDF) Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy
![WO2014154794A1 - Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders - Google Patents WO2014154794A1 - Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders - Google Patents](https://patentimages.storage.googleapis.com/96/26/8d/d26207fb6b8c23/imgf000042_0001.png)
WO2014154794A1 - Substituted oxopyridine derivatives and use thereof in the treatment of cardiovascular disorders - Google Patents
![PDF) Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy PDF) Topical nepafenac 0.1% alone versus prednisolone acetate 1% as postoperative anti-inflammatory agents in small gauge vitrectomy](https://i1.rgstatic.net/publication/262784411_Topical_nepafenac_01_alone_versus_prednisolone_acetate_1_as_postoperative_anti-inflammatory_agents_in_small_gauge_vitrectomy/links/5aba89300f7e9bad209bb955/largepreview.png)